Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer

Published:2024-01 Issue: Volume:253 Page:154994
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Ismail Yahia,Zakaria Al-Shimaa,Allam Rasha,Götte Martin,Ibrahim Sherif Abdelaziz,Hassan Hebatallah

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference39 articles.

1. Triple‑negative breast cancer therapy: Current and future perspectives (Review);Won;Int. J. Oncol.,2020

2. Triple-negative breast cancer molecular subtyping and treatment progress;Yin;Breast Cancer Res,2020

3. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment;Garrido-Castro;Cancer Discov.,2019

4. Clinicopathological characteristics of metaplastic breast cancer – analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types;Budzik;Breast,2019

5. Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study;Morgan;World J. Surg. Oncol.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP